Skip to main content
GeneBioTechCo.,Ltd. logo

GeneBioTechCo.,Ltd. — Investor Relations & Filings

Ticker · 086060 ISIN · KR7086060001 KO Manufacturing
Open in API
Filings indexed 120 across all filing types
Latest filing 2023-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 086060

About GeneBioTechCo.,Ltd.

http://www.gbtkorea.com

GeneBioTechCo.,Ltd., operating as GBTKOREA, is a specialized manufacturer of core components for medical X-ray imaging systems. Established in 2002, the company focuses on the design and production of high-frequency X-ray generators and related electronic systems. It provides comprehensive Original Equipment Manufacturer (OEM) customization services, developing tailored solutions for clients in the global medical equipment industry.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'GeneBioTech' (주)진바이오텍, covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '진바이오텍' covering the period from 2023-01-01 to 2023-06-30. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Genebiotech' (주)진바이오텍 for the period of Q1 2023 (2023.01.01-2023.03.31). It contains detailed financial statements, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, director/auditor appointments, and remuneration limits) from the meeting held on 2023-03-27. This falls directly under the definition of a Declaration of Voting Results.
2023-03-27 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2022 (2022.01.01-2022.12.31) for the company GeneBioTech. It contains detailed financial statements, management discussion and analysis, governance information, and operational data. In the context of South Korean regulatory filings (DART), this is the equivalent of an Annual Report (10-K). FY 2022
2023-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company Jinbiotech. It provides the auditor's opinion (which is 'unqualified' or 'appropriate'), financial highlights (assets, liabilities, revenue, profit/loss), and confirms the receipt of the audit report from the external auditor (Shinwoo Accounting Corp). While it contains financial data, it is a regulatory announcement of the audit results rather than the full 10-K annual report itself. In the context of Korean regulatory filings (DART), this is classified as an Audit Report/Information filing. FY 2022
2023-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.